Exagen Inc. XGN Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net?
- Exagen Inc. (XGN) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of $3.17M in Q1 2026.
- How has Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?
- Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net increased by 5186.7% year-over-year, from $60K to $3.17M.
- What is the long-term trend for Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net?
- Over 5 years (2020 to 2025), Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net has grown at a 62.0% compound annual growth rate (CAGR), from $296K to $3.3M.